Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesThe pharmacokinetic behavior of the soy isoflavone metabolite S-(–)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope labeled tracers
American Journal of Clinical Nutrition, 08/31/09
Setchell KDR et al. – The high bioavailability of both diastereoisomers contrasts with previous findings for the soy isoflavones daidzein and genistein, both of which have relatively poor bioavailability, and suggests that low doses of equol taken twice daily may be sufficient to achieve biological effects.
Today in Complementary Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
The Safety of Flavocoxid, a Medical Food, in the Dietary Management of Knee Osteoarthritis
Journal of Medicinal Food, 10/30/09
Colloidal silver - science or fraud?
The Clinical Advisor, 11/06/09
The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistance
Diabetes, Obesity and Metabolism, 11/12/09
Today in Pharmacokinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
U-500 Regular Insulin: Clinical Experience and Pharmacokinetics in Obese, Severely Insulin Resistant Type 2 Diabetic Patients
Diabetes Care, 11/16/09
The role of ceramide in major depressive disorder
European Archives of Psychiatry and Clinical Neuroscience, 11/12/09
Randomized Trial and Pharmacokinetic Study of Pegfilgrastim versus Filgrastim after Dose-Intensive Chemotherapy in Young Adults and Children with Sarcomas
Clinical Cancer Research, 11/20/09
Sponsor
Article Search
Sponsor